[{"NetIncomeLoss_1_Q3_USD":-29080000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":55077254.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":55188956.0,"InterestAndOtherIncome_3_Q3_USD":1913000.0,"InterestAndOtherIncome_1_Q3_USD":518000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"OperatingLeasesRentExpenseNet_3_Q3_USD":900000.0,"OperatingLeasesRentExpenseNet_1_Q3_USD":400000.0,"TreasuryStockCommonShares_0_Q3_shares":3021.0,"InterestPaidNet_3_Q3_USD":2960000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":69000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q3_USD":30500000.0,"RegulatoryLiabilityCurrent_0_Q3_USD":583000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-42129000.0,"GrantsReceivable_0_Q3_USD":1100000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":5730000.0,"PaymentsToAcquireInvestments_3_Q3_USD":132101000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":75000.0,"AssetsCurrent_0_Q3_USD":233214000.0,"FinanceLeaseLiabilityNoncurrent_0_Q3_USD":18946000.0,"FinanceLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":1689000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":12557728.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":12557728.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":587000.0,"FinanceLeaseInterestExpense_3_Q3_USD":1064000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":445000.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":35454000.0,"FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":405000.0,"CommonStockSharesIssued_0_Q3_shares":55204127.0,"Assets_0_Q3_USD":335496000.0,"UnrealizedGainLossOnInvestments_3_Q3_USD":49000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q3_USD":24830000.0,"ShareBasedCompensation_3_Q3_USD":12497000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":19720000.0,"OperatingLeaseLiability_0_Q3_USD":1327000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":226000.0,"ClassOfWarrantOrRightOutstanding_0_Q3_shares":14102.0,"ResearchAndDevelopmentExpense_3_Q3_USD":55345000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":21657000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":1428000.0,"FinanceLeasePrincipalPayments_3_Q3_USD":665000.0,"CommonStockValue_0_Q3_USD":552000.0,"DepositsAssetsNoncurrent_0_Q3_USD":455000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":1752000.0,"InterestPayableCurrent_0_Q3_USD":620000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":515000.0,"DepreciationDepletionAndAmortization_1_Q3_USD":300000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":546000.0,"RestrictedCashEquivalentsNoncurrent_0_Q3_USD":1568000.0,"ConvertibleLongTermNotesPayable_0_Q3_USD":42132000.0,"FinanceLeaseLiabilityPaymentsDue_0_Q3_USD":56032000.0,"ConvertibleNotesPayableCurrent_0_Q3_USD":4765000.0,"FairValueOfAssetsAcquired_3_Q3_USD":5627000.0,"FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":1644000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-78735000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-29240000.0,"ProceedsFromSaleOfTreasuryStock_3_Q3_USD":591000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":82226000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":599000.0,"Liabilities_0_Q3_USD":93655000.0,"ConstructionPayableCurrent_0_Q3_USD":5627000.0,"FinanceLeaseLiability_0_Q3_USD":20578000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-160000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":49000.0,"TreasuryStockCommonValue_0_Q3_USD":76000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q3_USD":228700000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":1094000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.01,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":874000.0,"CommonStockSharesOutstanding_0_Q3_shares":55201106.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":1420000.0,"FinanceLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.0896,"Goodwill_0_Q3_USD":30815000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":614000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":4047000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-61531000.0,"DefinedContributionPlanEmployerMatchingContributionPercent_3_Q3_pure":0.04,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":682000.0,"LiabilitiesCurrent_0_Q3_USD":31955000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_Q3_USD":-103114000.0,"PaymentsOfDebtIssuanceCosts_3_Q3_USD":237000.0,"InterestExpense_3_Q3_USD":5326000.0,"InterestExpense_1_Q3_USD":1967000.0,"LeaseCost_3_Q3_USD":2840000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":83794000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":4000.0,"DefinedContributionPlanEmployerDiscretionaryContributionAmount_3_Q3_USD":300000.0,"DefinedContributionPlanEmployerDiscretionaryContributionAmount_1_Q3_USD":81000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":545000.0,"FinanceLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":1736000.0,"FinanceLeaseRightOfUseAssetAmortization_3_Q3_USD":1166000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.0777,"FinanceLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":1791000.0,"AdditionalPaidInCapital_0_Q3_USD":503223000.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q3_USD":24.82,"OperatingLeasePayments_3_Q3_USD":671000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":100000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":15803000.0,"NetIncomeLoss_3_Q3_USD":-78784000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":4524000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-261927000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_3_Q3_USD":104111000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q3_USD":-244000.0,"PaymentsToAcquireSoftware_3_Q3_USD":646000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.01,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":101000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":1415000.0,"CommonStockSharesAuthorized_0_Q3_shares":120000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":0.0,"ImpairmentOfLongLivedAssetsHeldForUse_3_Q3_USD":62000.0,"OperatingIncomeLoss_3_Q3_USD":-75065000.0,"OperatingIncomeLoss_1_Q3_USD":-27387000.0,"PaymentsForRepurchaseOfCommonStock_3_Q3_USD":72000.0,"OperatingLeaseCost_3_Q3_USD":610000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":335496000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":2796000.0,"PreferredStockSharesAuthorized_0_Q3_shares":5000000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":12497000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":4047000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-306000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":6954000.0,"StockholdersEquity_0_Q3_USD":241841000.0,"FinanceLeaseLiabilityCurrent_0_Q3_USD":1632000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":23000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.53,"ShortTermInvestments_0_Q3_USD":146464000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.43,"OperatingExpenses_3_Q3_USD":75065000.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_3_Q3_USD":20179000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":728000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":17223000.0,"AmortizationOfDebtDiscountPremium_3_Q3_USD":2085000.0,"FinanceLeaseRightOfUseAsset_0_Q3_USD":52547000.0,"OperatingExpenses_1_Q3_USD":27387000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":894000.0,"Ticker":"RCKT","CIK":"1281895","name":"ROCKET PHARMACEUTICALS, INC.","OfficialName":"Rocket Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"879860326.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201106"}]